Document is current
Any future updates will be listed below
-
Authors
Ha, Ji Yeon
Kim, Dongwoo
Jebamani, Petrina
Park, Seong-Wook
Kim, Yong-Sung
Lee, Sun-Gu
Jung, Sang Taek
-
Funding
Funding for this research was provided by:
National Research Foundation of Korea (RS-2023-00245059)
Korea Drug Development Fund (RS-2024-00337233)
Seoul Metropolitan Government Seoul National University Boramae Medical Center (A0132-20250001)
- License Information
-
More Information
Article History
Received: 7 July 2025
Accepted: 24 October 2025
First Online: 5 December 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki and was approved by the Korea University Institutional Review Board (KUIRB-2021-0338-01). Human primary cells were obtained following the approved protocol, and informed consent was obtained from all donors prior to sample collection.
: Not applicable.
: The authors declare the following competing financial interest(s): S.T.J., J.Y.H., and D.K. filed a patent related to part of this study (KR 10-2025-0019356). The other authors declare no competing interests.
